FINWIRES · TerminalLIVE
FINWIRES

研究快讯:浦项控股第一季度业绩:电池材料亏损大幅收窄,利润大幅增长

By

-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师总结如下:浦项钢铁控股(POSCO Holdings)公布了强劲的2026年第一季度业绩,净利润从6930亿韩元飙升至4670亿韩元,营收环比增长6.1%至178760亿韩元,营业利润从130亿韩元跃升至7070亿韩元。业绩全面好转,电池材料业务亏损从1570亿韩元收窄至70亿韩元,基础设施业务也由亏损100亿韩元扭亏为盈,实现盈利4050亿韩元。尽管钢铁业务营业利润因利润率承压而环比下降35.8%。主要进展包括浦项钢铁阿根廷公司商业产能利用率达到70%,并与SK On公司签订了2028年前每年2.5万吨的供货协议。该公司宣布与JSW公司成立一家具有里程碑意义的合资企业,将在印度建设一座年产能600万吨的钢铁厂,这是其最大的海外投资项目,预计将于2031年完工。我们认为,浦项制铁的新股东回报政策旨在通过灵活的分红和股票回购,将调整后净利润的 35%-40% 返还给股东,再加上低碳举措(包括计划于 2026 年 6 月投产的 250 万吨/年的电炉),使公司在增长方面处于有利地位。

Related Articles

Mining & Metals

AltaGas' Q1 Normalized Net Income Rises YoY, On Track to Hit Top End of 2026 Guidance

AltaGas (ALA.TO) Thursday reported higher normalized net income in the first quarter and said it is on track to deliver 2026 results at the top end of its guidance.Normalized net income was C$415 million, or $1.33 per share, up from $342 million, or $1.14 per share. The result beat the non-GAAP earnings per share consensus estimate of $1.24 for the first quarter, as compiled by FactSet.Revenue held steady year over year at $3.97 billion. The result missed the sales consensus estimate of $4.13 billion, as compiled by FactSet.Normalized EBITDA was $818 million, up from $689 million.The growth in normalized EBITDA was attributed to higher global export volumes and margins, stronger processing and liquids handling margins, new utilities rates in D.C. and Virginia, strong asset optimization, and partial settlement of a pension liability.AltaGas expects to deliver 2026 results toward the top end of guidance for both normalized EBITDA and normalized EPS, with upside potential from continued LPG market strength.The company reiterated 2026 normalized EBITDA guidance of $1.925 billion to $2.025 billion; and normalized EPS guidance of $2.20 to $2.45.The company increased its 2026 capital program to $1.7 billion.

$ALA.TO
Research

UOB Kay Hian Downgrades AP Thailand to Hold from Buy; Price Target is THB8.50

$BKK:AP
Research

Maybank Research Upgrades Bumrungrad Hospital to Buy from Hold; Price Target is THB215

$BKK:BH